Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 82,447 | 29,927 | 18,844 | 16,507 | 16,765 |
| Marketable Securities | 237,203 | 19,472 | 83,510 | 46,365 | 55,213 |
| Receivables | 16,837 | 15,266 | 8,595 | 13,433 | 11,421 |
| Inventories | 14,230 | 13,312 | 17,878 | 23,065 | 15,634 |
| TOTAL | $355,587 | $81,046 | $131,659 | $101,619 | $109,011 |
| Non-Current Assets | |||||
| PPE Net | 24,899 | 30,070 | 34,073 | 37,920 | 14,560 |
| Other Non-Current Assets | 33,494 | 36,869 | 4,543 | 4,545 | 14,313 |
| TOTAL | $58,393 | $66,939 | $38,616 | $42,465 | $28,873 |
| Total Assets | $413,980 | $147,985 | $170,275 | $144,084 | $137,884 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,579 | 8,368 | 6,736 | 9,093 | 8,359 |
| Accrued Expenses | 17,350 | 13,242 | 12,823 | 12,618 | 16,604 |
| Other current liabilities | 4,519 | 225 | 788 | 605 | 1,681 |
| TOTAL | $38,502 | $49,153 | $26,884 | $28,635 | $33,774 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 14,659 | 13,635 | 16,106 |
| Deferred Revenues | 8,722 | 7,610 | 6,537 | 6,319 | 7,130 |
| Other Non-Current Liabilities | 38,419 | 41,964 | 16 | 14,636 | 2,020 |
| TOTAL | $39,987 | $43,915 | $29,330 | $29,346 | $19,442 |
| Total Liabilities | $78,489 | $93,068 | $56,214 | $57,981 | $53,216 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 193,103 | 153,136 | 150,960 | 130,694 | 92,725 |
| Common Shares | 192 | 153 | 150 | 116 | 93 |
| Retained earnings | -1,036,869 | -1,066,240 | -982,106 | -879,733 | -787,544 |
| Other shareholders' equity | 85 | 5 | -36 | -32 | 5 |
| TOTAL | $335,491 | $54,917 | $114,061 | $86,103 | $84,668 |
| Total Liabilities And Equity | $413,980 | $147,985 | $170,275 | $144,084 | $137,884 |